CAPRICOR THERAPEUTICS, INC. - 8-K Filing
Capricor Therapeutics signed a lease for new headquarters in San Diego contingent on FDA approval by December 31, 2026. (Items: 1.01 of this Current Report on Form 8-K is hereby incorporated in this Item 2)
Tickers: $CAPR